At a glance
ClinicalIndex Comparison RecordN/ACompleted· 94 enrolled
Drug / intervention
PhotoFixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-market, Prospective Evaluation of PHOTO-oxidized Decellularized Bovine Pericardium Used as a Patch in Vascular Repair and Reconstruction Surgery
In Brief
A clinical study evaluating PhotoFix for Vascular Diseases and 4 related conditions. Completed, enrolled 94 participants across 9 sites.
Detailed Summary
The objective of this post-market clinical follow-up study is to evaluate the clinical outcomes of patients receiving PhotoFix as a patch within a vascular repair or reconstruction procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVascular Diseases, Peripheral Arterial Disease, Hemodialysis Access Failure (Disorder), Carotid Artery Diseases, Abdominal Aortic Aneurism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartNov 2018
Primary CompletionJul 2020
TodayJul 2026
First PostedSep 13, 2018
Enrollment StartNov 20, 2018
Primary CompletionJul 10, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.8 years ago
Interventions
PhotoFixdevice
PhotoFix Patch Implantation